Top Markets
Coin of the day
Purple Biotech Ltd. Purple Biotech Ltd.

Purple Biotech Ltd.

PPBT
Ранг среди акций #40643
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies... Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.
Цена акции
$0.00323826
Последняя синхронизация: 2026-08-12
Рыночная капитализация
$104.81K
Изменение (1 день)
0.00%
Изменение (1 год)
-70.42%
Страна
IL
Торговля Purple Biotech Ltd. (PPBT)

Категория

цена PPBT с рыночной капитализацией B
Purple Biotech Ltd. Purple Biotech Ltd.
PPBT
$0.00323826
Рыночная капитализация Purple Biotech Ltd.(PPBT)
Рыночная капитализация: $104.81K
По состоянию на August 2026 рыночная капитализация Purple Biotech Ltd. составляет $104.81K. Согласно нашим данным, Purple Biotech Ltd. занимает 40643rd место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Purple Biotech Ltd. с 2002 по 2026
PPBT по сравнению с пятеркой самых популярных stocks
Цена за PPBT Актив Б Рыночная капитализация B результаты
Purple Biotech Ltd. Purple Biotech Ltd.
$168,816 $104.81K
$5.464T +5,213,177,351.82%
Purple Biotech Ltd. Purple Biotech Ltd.
$137,583 $104.81K
$4.453T +4,248,651,815.00%
Purple Biotech Ltd. Purple Biotech Ltd.
$128,854 $104.81K
$4.170T +3,979,107,044.83%
Purple Biotech Ltd. Purple Biotech Ltd.
$113,251 $104.81K
$3.665T +3,497,286,439.25%
Purple Biotech Ltd. Purple Biotech Ltd.
$88,120.33 $104.81K
$2.852T +2,721,221,589.97%